Relapsing TIPIC Syndrome after Administration of an mRNA-Based COVID-19 Vaccine.
Georgiana C SanduGregor WeisserStefan KrämerMatthias ReinhardPublished in: Case reports in vascular medicine (2023)
Reported vascular complications following mRNA-based COVID-19 vaccines are consisting of myocarditis, cerebral venous thrombosis, cerebral vascular thrombosis, and vaccine-induced thrombocytopenia. Here, we describe a case of a 49-year-old woman with left-sided pain above the middle common carotid artery (carotidynia) starting a few days after her second vaccination with an mRNA-based COVID-19 vaccine (Spikevax). Imaging was indicative of transient perivascular inflammation of the carotid artery (TIPIC) syndrome. The diagnostic workup for other immunologically mediated diseases was negative. The inflammation subsided after a course of prednisone and aspirin, and clinical symptoms vanished, but later mildly relapsed in the context of a viral upper respiratory tract infection other than SARS-CoV-2. Carotidynia because of TIPIC syndrome may present as an immunogenic side effect of the newly developed mRNA-based vaccinations against COVID-19. TIPIC syndrome should be considered in new-onset neck pain after vaccination.
Keyphrases
- sars cov
- coronavirus disease
- respiratory syndrome coronavirus
- case report
- respiratory tract
- oxidative stress
- low dose
- binding protein
- pulmonary embolism
- chronic pain
- acute myeloid leukemia
- type diabetes
- diffuse large b cell lymphoma
- risk factors
- spinal cord
- neuropathic pain
- cardiovascular events
- coronary artery disease
- pain management
- multiple myeloma
- diabetic rats
- cardiovascular disease
- percutaneous coronary intervention
- high resolution
- drug induced
- atrial fibrillation
- disease activity